155 related articles for article (PubMed ID: 24735796)
21. Peroxisome proliferator-activated receptor gamma-dependent activation of p21 in Panc-28 pancreatic cancer cells involves Sp1 and Sp4 proteins.
Hong J; Samudio I; Liu S; Abdelrahim M; Safe S
Endocrinology; 2004 Dec; 145(12):5774-85. PubMed ID: 15345676
[TBL] [Abstract][Full Text] [Related]
22. Suppression of Src/ERK and GSK-3/β-catenin signaling by pinosylvin inhibits the growth of human colorectal cancer cells.
Park EJ; Chung HJ; Park HJ; Kim GD; Ahn YH; Lee SK
Food Chem Toxicol; 2013 May; 55():424-33. PubMed ID: 23333577
[TBL] [Abstract][Full Text] [Related]
23. Activation of peroxisome proliferator-activated receptor gamma inhibits cell growth via apoptosis and arrest of the cell cycle in human colorectal cancer.
Lin MS; Chen WC; Bai X; Wang YD
J Dig Dis; 2007 May; 8(2):82-8. PubMed ID: 17532820
[TBL] [Abstract][Full Text] [Related]
24. Anticancer activity of calyx of Diospyros kaki Thunb. through downregulation of cyclin D1 via inducing proteasomal degradation and transcriptional inhibition in human colorectal cancer cells.
Park SB; Park GH; Song HM; Son HJ; Um Y; Kim HS; Jeong JB
BMC Complement Altern Med; 2017 Sep; 17(1):445. PubMed ID: 28870200
[TBL] [Abstract][Full Text] [Related]
25. SATB2/β-catenin/TCF-LEF pathway induces cellular transformation by generating cancer stem cells in colorectal cancer.
Yu W; Ma Y; Shankar S; Srivastava RK
Sci Rep; 2017 Sep; 7(1):10939. PubMed ID: 28887549
[TBL] [Abstract][Full Text] [Related]
26. Quercetin inhibit human SW480 colon cancer growth in association with inhibition of cyclin D1 and survivin expression through Wnt/beta-catenin signaling pathway.
Shan BE; Wang MX; Li RQ
Cancer Invest; 2009 Jul; 27(6):604-12. PubMed ID: 19440933
[TBL] [Abstract][Full Text] [Related]
27. UCHL1 acts as a colorectal cancer oncogene via activation of the β-catenin/TCF pathway through its deubiquitinating activity.
Zhong J; Zhao M; Ma Y; Luo Q; Liu J; Wang J; Yuan X; Sang J; Huang C
Int J Mol Med; 2012 Aug; 30(2):430-6. PubMed ID: 22641175
[TBL] [Abstract][Full Text] [Related]
28. The β-catenin/TCF complex as a novel target of resveratrol in the Wnt/β-catenin signaling pathway.
Chen HJ; Hsu LS; Shia YT; Lin MW; Lin CM
Biochem Pharmacol; 2012 Nov; 84(9):1143-53. PubMed ID: 22935447
[TBL] [Abstract][Full Text] [Related]
29. Activation of peroxisome proliferator-activated receptor gamma by a novel synthetic triterpenoid 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid induces growth arrest and apoptosis in breast cancer cells.
Lapillonne H; Konopleva M; Tsao T; Gold D; McQueen T; Sutherland RL; Madden T; Andreeff M
Cancer Res; 2003 Sep; 63(18):5926-39. PubMed ID: 14522919
[TBL] [Abstract][Full Text] [Related]
30. Peroxisome proliferator-activated receptor γ-mediated induction of microRNA-145 opposes tumor phenotype in colorectal cancer.
Panza A; Votino C; Gentile A; Valvano MR; Colangelo T; Pancione M; Micale L; Merla G; Andriulli A; Sabatino L; Vinciguerra M; Prattichizzo C; Mazzoccoli G; Colantuoni V; Piepoli A
Biochim Biophys Acta; 2014 Jun; 1843(6):1225-36. PubMed ID: 24631504
[TBL] [Abstract][Full Text] [Related]
31. Docosahexaenoic acid induces proteasome-dependent degradation of beta-catenin, down-regulation of survivin and apoptosis in human colorectal cancer cells not expressing COX-2.
Calviello G; Resci F; Serini S; Piccioni E; Toesca A; Boninsegna A; Monego G; Ranelletti FO; Palozza P
Carcinogenesis; 2007 Jun; 28(6):1202-9. PubMed ID: 17183061
[TBL] [Abstract][Full Text] [Related]
32. Salinomycin exerts anti-colorectal cancer activity by targeting the β-catenin/T-cell factor complex.
Wang Z; Zhou L; Xiong Y; Yu S; Li H; Fan J; Li F; Su Z; Song J; Sun Q; Liu SS; Xia Y; Zhao L; Li S; Guo F; Huang P; Carson DA; Lu D
Br J Pharmacol; 2019 Sep; 176(17):3390-3406. PubMed ID: 31236922
[TBL] [Abstract][Full Text] [Related]
33. Regulation of Wnt signaling by the nuclear pore complex.
Shitashige M; Satow R; Honda K; Ono M; Hirohashi S; Yamada T
Gastroenterology; 2008 Jun; 134(7):1961-71, 1971.e1-4. PubMed ID: 18439914
[TBL] [Abstract][Full Text] [Related]
34. Ergosterol peroxide from Chaga mushroom (Inonotus obliquus) exhibits anti-cancer activity by down-regulation of the β-catenin pathway in colorectal cancer.
Kang JH; Jang JE; Mishra SK; Lee HJ; Nho CW; Shin D; Jin M; Kim MK; Choi C; Oh SH
J Ethnopharmacol; 2015 Sep; 173():303-12. PubMed ID: 26210065
[TBL] [Abstract][Full Text] [Related]
35. ITF2 prevents activation of the β-catenin-TCF4 complex in colon cancer cells and levels decrease with tumor progression.
Shin HW; Choi H; So D; Kim YI; Cho K; Chung HJ; Lee KH; Chun YS; Cho CH; Kang GH; Kim WH; Park JW
Gastroenterology; 2014 Aug; 147(2):430-442.e8. PubMed ID: 24846398
[TBL] [Abstract][Full Text] [Related]
36. [Mechanism of Wnt signaling pathway regulation by a truncated mutant of Axin2 in colorectal cancer].
Wang FW; Wen L; Zhu SW; Yao Q; Cai YM; Ma G
Ai Zheng; 2007 Oct; 26(10):1041-6. PubMed ID: 17927870
[TBL] [Abstract][Full Text] [Related]
37. Thiazolidinedione, a peroxisome proliferator-activated receptor-gamma ligand, inhibits growth and metastasis of HT-29 human colon cancer cells through differentiation-promoting effects.
Yoshizumi T; Ohta T; Ninomiya I; Terada I; Fushida S; Fujimura T; Nishimura G; Shimizu K; Yi S; Miwa K
Int J Oncol; 2004 Sep; 25(3):631-9. PubMed ID: 15289864
[TBL] [Abstract][Full Text] [Related]
38. Ginsenoside Rg3 inhibits colorectal tumor growth through the down-regulation of Wnt/ß-catenin signaling.
He BC; Gao JL; Luo X; Luo J; Shen J; Wang L; Zhou Q; Wang YT; Luu HH; Haydon RC; Wang CZ; Du W; Yuan CS; He TC; Zhang BQ
Int J Oncol; 2011 Feb; 38(2):437-45. PubMed ID: 21152855
[TBL] [Abstract][Full Text] [Related]
39. Periplocin from Cortex periplocae inhibits cell growth and down-regulates survivin and c-myc expression in colon cancer in vitro and in vivo via beta-catenin/TCF signaling.
Zhao L; Shan B; Du Y; Wang M; Liu L; Ren FZ
Oncol Rep; 2010 Aug; 24(2):375-83. PubMed ID: 20596624
[TBL] [Abstract][Full Text] [Related]
40. The nonsteroidal anti-inflammatory drugs aspirin and indomethacin attenuate beta-catenin/TCF-4 signaling.
Dihlmann S; Siermann A; von Knebel Doeberitz M
Oncogene; 2001 Feb; 20(5):645-53. PubMed ID: 11313997
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]